METFORMIN: A REVIEW OF THE LITERATURE

Detalhes bibliográficos
Autor(a) principal: Rodrigues Neto, Edilson Martins
Data de Publicação: 2015
Outros Autores: Marques, Lidia Audrey Rocha Valadas, Ferreira, Maria Augusta Drago, Lobo, Patricia Leal Dantas, Girão Junior, Francisco Josimar, Camarão, Gisela Costa, Moraes, Maria Elisabete Amaral de
Tipo de documento: Artigo
Idioma: por
Título da fonte: Saúde e Pesquisa (Online)
Texto Completo: https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4105
Resumo: Metformin, commercialized under several trademarks and also as a generic medicine, is an oral anti-diabetic drug, belonging to the biguanide class. It is actually the first choice in the treatment of Type 2 diabetes mellitus (DM2) due to its toxicity and clinical efficaciousness. It extensive use requires a constant discussion on its characteristics and applications. Current paper is a bibliographical review comprising the application of metformin in DM2 treatment as its chemical, physical-chemical, pharmacokinetic, pharmacodynamics properties, its clinical usages, contraindications and side effects. Review occurred in Pubmed, Bireme, Lilacs and SciELO data banks and in research in journals published on the Brazilian Platform in Scientific Information and in books on the subject. Results show that metformin is the best medicine for diabetic patients, with auxiliary therapy for other physiological disorders.
id CESUMAR-1_942aee8ff68e52a8727995707611e689
oai_identifier_str oai:ojs.pkp.sfu.ca:article/4105
network_acronym_str CESUMAR-1
network_name_str Saúde e Pesquisa (Online)
repository_id_str
spelling METFORMIN: A REVIEW OF THE LITERATUREMetformina: Uma Revisão da LiteraturaBiguanidesDiabetes Mellitus type 2MetforminBiguanidasDiabetes mellitus tipo 2MetforminaMetformin, commercialized under several trademarks and also as a generic medicine, is an oral anti-diabetic drug, belonging to the biguanide class. It is actually the first choice in the treatment of Type 2 diabetes mellitus (DM2) due to its toxicity and clinical efficaciousness. It extensive use requires a constant discussion on its characteristics and applications. Current paper is a bibliographical review comprising the application of metformin in DM2 treatment as its chemical, physical-chemical, pharmacokinetic, pharmacodynamics properties, its clinical usages, contraindications and side effects. Review occurred in Pubmed, Bireme, Lilacs and SciELO data banks and in research in journals published on the Brazilian Platform in Scientific Information and in books on the subject. Results show that metformin is the best medicine for diabetic patients, with auxiliary therapy for other physiological disorders.A metformina, medicamento comercializado por diversas marcas e também na forma de genérico, é um antidiabético oral pertencente à classe das biguanidas. Devido ao seu perfil de toxicidade e à sua eficácia clínica é a principal escolha no tratamento do diabetes mellitus tipo dois (DM2). Pelo seu grande uso é necessária uma discussão constante a respeito de suas características e aplicações. Objetivou-se realizar uma revisão bibliográfica, na qual serão abordadas a aplicação da metformina no tratamento de DM2 bem como suas propriedades químicas, físico-químicas, farmacocinéticas, farmacodinâmicas, seus usos clínicos, contraindicações e efeitos adversos. Revisão da literatura realizada nos bancos de dados Pubmed, Bireme, Lilacs e Scielo, bem como pesquisa nos periódicos do Portal Brasileiro da Informação Científica e livros sobre o assunto. Pelo exposto percebe-se que a metformina para pacientes diabéticos é considerada um fármaco ideal tendo ainda aplicações na terapêutica adjuvante de outros distúrbios fisiológicos.Universidade Cesumar - UniCesumar2015-09-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/410510.17765/1983-1870.2015v8n2p355-362Saúde e Pesquisa; Vol 8 No 2 (2015): maio/ago.; 355-362Saúde e Pesquisa; v. 8 n. 2 (2015): maio/ago.; 355-3622176-9206reponame:Saúde e Pesquisa (Online)instname:Cesumar Diretoria de Pesquisainstacron:CESUMARporhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4105/2641Rodrigues Neto, Edilson MartinsMarques, Lidia Audrey Rocha ValadasFerreira, Maria Augusta DragoLobo, Patricia Leal DantasGirão Junior, Francisco JosimarCamarão, Gisela CostaMoraes, Maria Elisabete Amaral deinfo:eu-repo/semantics/openAccess2021-12-09T11:28:50Zoai:ojs.pkp.sfu.ca:article/4105Revistahttps://periodicos.unicesumar.edu.br/index.php/saudpesqPUBhttps://periodicos.unicesumar.edu.br/index.php/saudpesq/oainaep@cesumar.br2176-92061983-1870opendoar:2021-12-09T11:28:50Saúde e Pesquisa (Online) - Cesumar Diretoria de Pesquisafalse
dc.title.none.fl_str_mv METFORMIN: A REVIEW OF THE LITERATURE
Metformina: Uma Revisão da Literatura
title METFORMIN: A REVIEW OF THE LITERATURE
spellingShingle METFORMIN: A REVIEW OF THE LITERATURE
Rodrigues Neto, Edilson Martins
Biguanides
Diabetes Mellitus type 2
Metformin
Biguanidas
Diabetes mellitus tipo 2
Metformina
title_short METFORMIN: A REVIEW OF THE LITERATURE
title_full METFORMIN: A REVIEW OF THE LITERATURE
title_fullStr METFORMIN: A REVIEW OF THE LITERATURE
title_full_unstemmed METFORMIN: A REVIEW OF THE LITERATURE
title_sort METFORMIN: A REVIEW OF THE LITERATURE
author Rodrigues Neto, Edilson Martins
author_facet Rodrigues Neto, Edilson Martins
Marques, Lidia Audrey Rocha Valadas
Ferreira, Maria Augusta Drago
Lobo, Patricia Leal Dantas
Girão Junior, Francisco Josimar
Camarão, Gisela Costa
Moraes, Maria Elisabete Amaral de
author_role author
author2 Marques, Lidia Audrey Rocha Valadas
Ferreira, Maria Augusta Drago
Lobo, Patricia Leal Dantas
Girão Junior, Francisco Josimar
Camarão, Gisela Costa
Moraes, Maria Elisabete Amaral de
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Rodrigues Neto, Edilson Martins
Marques, Lidia Audrey Rocha Valadas
Ferreira, Maria Augusta Drago
Lobo, Patricia Leal Dantas
Girão Junior, Francisco Josimar
Camarão, Gisela Costa
Moraes, Maria Elisabete Amaral de
dc.subject.por.fl_str_mv Biguanides
Diabetes Mellitus type 2
Metformin
Biguanidas
Diabetes mellitus tipo 2
Metformina
topic Biguanides
Diabetes Mellitus type 2
Metformin
Biguanidas
Diabetes mellitus tipo 2
Metformina
description Metformin, commercialized under several trademarks and also as a generic medicine, is an oral anti-diabetic drug, belonging to the biguanide class. It is actually the first choice in the treatment of Type 2 diabetes mellitus (DM2) due to its toxicity and clinical efficaciousness. It extensive use requires a constant discussion on its characteristics and applications. Current paper is a bibliographical review comprising the application of metformin in DM2 treatment as its chemical, physical-chemical, pharmacokinetic, pharmacodynamics properties, its clinical usages, contraindications and side effects. Review occurred in Pubmed, Bireme, Lilacs and SciELO data banks and in research in journals published on the Brazilian Platform in Scientific Information and in books on the subject. Results show that metformin is the best medicine for diabetic patients, with auxiliary therapy for other physiological disorders.
publishDate 2015
dc.date.none.fl_str_mv 2015-09-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4105
10.17765/1983-1870.2015v8n2p355-362
url https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4105
identifier_str_mv 10.17765/1983-1870.2015v8n2p355-362
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.unicesumar.edu.br/index.php/saudpesq/article/view/4105/2641
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Cesumar - UniCesumar
publisher.none.fl_str_mv Universidade Cesumar - UniCesumar
dc.source.none.fl_str_mv Saúde e Pesquisa; Vol 8 No 2 (2015): maio/ago.; 355-362
Saúde e Pesquisa; v. 8 n. 2 (2015): maio/ago.; 355-362
2176-9206
reponame:Saúde e Pesquisa (Online)
instname:Cesumar Diretoria de Pesquisa
instacron:CESUMAR
instname_str Cesumar Diretoria de Pesquisa
instacron_str CESUMAR
institution CESUMAR
reponame_str Saúde e Pesquisa (Online)
collection Saúde e Pesquisa (Online)
repository.name.fl_str_mv Saúde e Pesquisa (Online) - Cesumar Diretoria de Pesquisa
repository.mail.fl_str_mv naep@cesumar.br
_version_ 1754122533493276672